MedPage Today1d
Time to Reconsider MRI to Detect Asymptomatic Brain Mets in Breast Cancer?
The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
MP wants to dispel secondary breast cancer myths
An MP diagnosed with breast cancer for a second time wants to "debunk" misconceptions about metastatic cancers. Labour MP for ...
Verywell Health on MSN1d
Navigating Care Through Every Phase of Metastatic Breast Cancer
If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...
Verywell Health on MSN1d
8 Ways to Combat Isolation With a Metastatic Breast Cancer Diagnosis
Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...
Metastatic Breast Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight
DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...
Cure Today1d
Strutting Into Year 11 With Metastatic Breast Cancer
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...
Science Daily7d
Routine brain MRI screening in asymptomatic late stage breast cancer patients
A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to rethink current screening ...
FDA approves Datroway for HR-positive, HER2-negative breast cancer
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
Asymptomatic brain metastasis in stage 4 breast cancer requires reevaluation of screening guidelines
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed.
Cure Today4d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...